FDA approves 'female Viagra' pill Flibanserin after two rejections

Drug to help women boost sex drive overcomes concerns over effectiveness and side effects, but some experts fear precedent campaigning could set

The FDA has finally approved the little pink pill to help women boost their sex drive.

Flibanserin, to be sold as Addyi, finally got a green light from the US Food and Drug Administration on Tuesday. This was the third time the agency has considered approval for the drug, which is intended for women diagnosed with hypoactive sexual desire disorder (HSDD).

Related: 'Female viagra': FDA panel backs Flibanserin with safety restriction

Related: We shouldn't push dubious 'pink Viagra' pills on women and call it emancipation | Barbara Mintzes and Leonore Tiefer

Continue reading...